⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 28, 2024BiomedicinesOpen Access

Cannabidiol and Beta-Caryophyllene Combination Attenuates Diabetic Neuropathy by Inhibiting NLRP3 Inflammasome/NFκB through the AMPK/sirT3/Nrf2 Axis

Islauddin Khan Sukhmandeep Kaur Arun K. Rishi Breana Boire Mounika Aare Mandip Singh

View Full Paper

Ask AI

Bookmark

Share

Abstract

In this study, we investigated in detail the role of cannabidiol (CBD), beta-caryophyllene (BC), or their combinations in diabetic peripheral neuropathy (DN). The key factors that contribute to DN include mitochondrial dysfunction, inflammation, and oxidative stress.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Khan et al. (2024) studied this question.

synapsesocial.com/papers/68e62ad5b6db6435875bdef4 https://doi.org/10.3390/biomedicines12071442

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cannabidiol and Beta-Caryophyllene Combination Attenuates Diabetic Neuropathy by Inhibiting NLRP3 Inflammasome/NFκB through the AMPK/SIRT3/Nrf2 Axis2024 · 8 citations
2Anti-Inflammatory Properties of Cannabidiol and Beta-Caryophyllene Alone or Combined in an In Vitro Inflammation Model2024 · 10 citations
3Cannabinoid 2 Receptor Activation Mitigates High-Fat Diet/Streptozotocin-Induced Nonalcoholic Fatty Liver Disease in Diabetic Mice by Modulation of Oxidative Stress, Inflammation, and FibrosisOriginal Research · 2026
4Cannabidiol as a modulator of NLRP3 inflammasome: Mechanistic insights and therapeutic potentialHuman Clinical Trial · 2026 · 2 citations
5Neuroprotective effect of Bergenin in diabetic neuropathy: modulation of AMPK and NF-κB signalingOriginal Research · 2025 · 2 citations